Imiquimod-induced vitiligo-like depigmentation [1]

Indian Journal of Dermatology, Venereology and Leprology

Volumn 73, Issue 6, 2007, Pages 423-

  Şenel, Engin ^a   Seçkin, Deniz ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD;

ADULT; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; CONDYLOMA; DEPIGMENTATION; DISEASE COURSE; DISEASE PREDISPOSITION; DRUG EFFECT; DRUG MECHANISM; ERYTHEMA; FOLLOW UP; HUMAN; LABORATORY TEST; LETTER; MALE; OUTCOME ASSESSMENT; PHYSICAL EXAMINATION; SKIN EDEMA; VITILIGO;

EID: 36448979617     PISSN: 03786323     EISSN: None     Source Type: Journal    
DOI: 10.4103/0378-6323.37065     Document Type: Letter

References (5)

1. Rudy SJ. Imiquimod (Aldara): Modifying the immune response. Dermatol Nurs 2002;14:268-70.
2. Majewski S, Marczak M, Mlynarczyk B, Benninghoff B, Jablonska S. Imiquimod is a strong inhibitor of tumor cell-induced angiogenesis. Int J Dermatol 2005;44:14-9.
3. Brown T, Zirvi M, Cotsarelis G, Gelfand JM. Vitiligo-like hypopigmentation associated with imiquimod treatment of genital warts. J Am Acad Dermatol 2005;52:715-6.
4. Stefanaki C, Nicolaidou E, Hadjivassiliou M, Antoniou C, Katsambas A. Imiquimod-induced vitiligo in a patient with genital warts. J Eur Acad Dermatol Venereol 2006;20:755-6.
5. Eedy DJ. Imiquimod: A potential role in dermatology? Br J Dermatol 2002;147:1-6.